Download PDF
Thromb Haemost 2002; 88(03): 539-540
DOI: 10.1055/s-0037-1613252
Letters to the Editor
Schattauer GmbH

Transition from Unfractionated Heparin to Low Molecular Weight Heparins

William A. Ghali
1   Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Andre Pannatier
2   The Faculty of Medicine, University of Lausanne, Lausanne, Switzerland
,
Ross T. Tsuyuki
3   The Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada
,
Russell D. Hull
1   Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Elizabeth MacKay
1   Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Hude Quan
1   Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada
,
Jacques Cornuz
2   The Faculty of Medicine, University of Lausanne, Lausanne, Switzerland
› Author Affiliations
Further Information

Publication History

Received 29 March 2002

Accepted after resubmission 06 May 2002

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Weitz JI. Drug Therapy: Low-Molecular-Weight Heparins. N Engl J Med 1997; 337: 688-99.
    CrossrefPubMedGoogle Scholar
  • 2 Geerts WH, Jay RM, Code KI. et al. A Comparison of Low-Dose Heparin with Low-Molecular-Weight Heparin as Prophylaxis against Venous Thromboembolism after Major Trauma. N Engl J Med 1996; 335: 701-7.
    CrossrefPubMedGoogle Scholar
  • 3 Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low molecular weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis. A meta-analysis of randomized controlled trials. Ann Intern Med 1999; 130: 800-9.
    CrossrefPubMedGoogle Scholar
  • 4 Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S. Unfractionated heparin and low molecular weight heparin in acute coronary syndromes without ST elevation: a meta-analysis. Lancet 2000; 355: 1936-42.
    CrossrefPubMedGoogle Scholar
  • 5 Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low molecular weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis. A cost-effectiveness analysis. Ann Intern Med 1999; 130: 789-99.
    CrossrefPubMedGoogle Scholar